Electron paramagnetic resonance (EPR) spectroscopy has been applied to investigate unusual phenomena observed in the photoluminescence of manganese(ii)containing zinc and cadmium sulfide materials. For manganese(ii) in zinc sulfide the g value and the hyperfine splitting constant are barely dependent on the type of material (polycrystalline powder, thin film, superlattice). An anomalous emission of the polycrystalline ZnS : Mn powders calcined at 90&1000°C in the vicinity of 520 nm is ascribed to manganese(ii) in an environment with a large distortion due to oxygen impurities. For the thin films and superlattices unusual EPR spectra are observed when manganese(ii) is present in cadmium sulfide: a large cubic splitting parameter of 53.8 x cm-' for the thin films of CdS : Mn on BaF2(111) reflects the strain due to different thermal expansions of cadmium sulfide and barium fluoride. A negative g-shift of 0.0014 for the superlattices of CdS : Mn-ZnS on BaF2(111) compared with that for the free electron implies that the covalency between manganese(ii) and the environment in cadmium sulfide is affected significantly by the lattice mismatch between the alternate layers of zinc and cadmium sulfides.
Mn-doped CdSSeTe–ZnS superlattices (SLs) have been prepared by a hot wall technique, and double insulating electroluminescent devices of the SL layers have been prepared. The red shifted emission of 10–100 nm wavelength have been observed due to the high strain by the large lattice mismatches (7.5–16%). The characteristics of the most shifted one (CdTe–ZnS case) are the peak photon wavelength of 675 nm and the luminance of 450 cd/m2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.